255 related articles for article (PubMed ID: 17555712)
1. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D.
Shin S; Janknecht R
Biochem Biophys Res Commun; 2007 Aug; 359(3):742-6. PubMed ID: 17555712
[TBL] [Abstract][Full Text] [Related]
2. Diversity within the JMJD2 histone demethylase family.
Shin S; Janknecht R
Biochem Biophys Res Commun; 2007 Feb; 353(4):973-7. PubMed ID: 17207460
[TBL] [Abstract][Full Text] [Related]
3. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
[TBL] [Abstract][Full Text] [Related]
4. Comparative integromics on JMJD2A, JMJD2B and JMJD2C: preferential expression of JMJD2C in undifferentiated ES cells.
Katoh Y; Katoh M
Int J Mol Med; 2007 Aug; 20(2):269-73. PubMed ID: 17611647
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of JMJD2 family genes in silico.
Katoh M; Katoh M
Int J Oncol; 2004 Jun; 24(6):1623-8. PubMed ID: 15138608
[TBL] [Abstract][Full Text] [Related]
6. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases.
Whetstine JR; Nottke A; Lan F; Huarte M; Smolikov S; Chen Z; Spooner E; Li E; Zhang G; Colaiacovo M; Shi Y
Cell; 2006 May; 125(3):467-81. PubMed ID: 16603238
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
Kahl P; Gullotti L; Heukamp LC; Wolf S; Friedrichs N; Vorreuther R; Solleder G; Bastian PJ; Ellinger J; Metzger E; Schüle R; Buettner R
Cancer Res; 2006 Dec; 66(23):11341-7. PubMed ID: 17145880
[TBL] [Abstract][Full Text] [Related]
8. Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A.
Huang Y; Fang J; Bedford MT; Zhang Y; Xu RM
Science; 2006 May; 312(5774):748-51. PubMed ID: 16601153
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity.
Ng SS; Kavanagh KL; McDonough MA; Butler D; Pilka ES; Lienard BM; Bray JE; Savitsky P; Gileadi O; von Delft F; Rose NR; Offer J; Scheinost JC; Borowski T; Sundstrom M; Schofield CJ; Oppermann U
Nature; 2007 Jul; 448(7149):87-91. PubMed ID: 17589501
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.
Wang LG; Johnson EM; Kinoshita Y; Babb JS; Buckley MT; Liebes LF; Melamed J; Liu XM; Kurek R; Ossowski L; Ferrari AC
Cancer Res; 2008 Apr; 68(8):2678-88. PubMed ID: 18413735
[TBL] [Abstract][Full Text] [Related]
11. A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR.
Wolf SS; Patchev VK; Obendorf M
Arch Biochem Biophys; 2007 Apr; 460(1):56-66. PubMed ID: 17353003
[TBL] [Abstract][Full Text] [Related]
12. c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer.
Cai C; Hsieh CL; Shemshedini L
Mol Cancer Res; 2007 Jul; 5(7):725-35. PubMed ID: 17634427
[TBL] [Abstract][Full Text] [Related]
13. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
14. Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell.
Léotoing L; Meunier L; Manin M; Mauduit C; Decaussin M; Verrijdt G; Claessens F; Benahmed M; Veyssière G; Morel L; Beaudoin C
Oncogene; 2008 May; 27(20):2858-67. PubMed ID: 18037965
[TBL] [Abstract][Full Text] [Related]
15. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into histone demethylation by JMJD2 family members.
Chen Z; Zang J; Whetstine J; Hong X; Davrazou F; Kutateladze TG; Simpson M; Mao Q; Pan CH; Dai S; Hagman J; Hansen K; Shi Y; Zhang G
Cell; 2006 May; 125(4):691-702. PubMed ID: 16677698
[TBL] [Abstract][Full Text] [Related]
17. Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase.
Couture JF; Collazo E; Ortiz-Tello PA; Brunzelle JS; Trievel RC
Nat Struct Mol Biol; 2007 Aug; 14(8):689-95. PubMed ID: 17589523
[TBL] [Abstract][Full Text] [Related]
18. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
Metzger E; Wissmann M; Yin N; Müller JM; Schneider R; Peters AH; Günther T; Buettner R; Schüle R
Nature; 2005 Sep; 437(7057):436-9. PubMed ID: 16079795
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
20. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
Zhang J; Li Q; Zhang S; Xu Q; Wang T
Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
